Impact of Bone Mineral Density on the Incidence of Age-Related Vertebral Fragility Fracture

다국어 초록 (Multilingual Abstract)

Background: Vertebral fragility fracture (VFF) is a common fracture related to osteoporosis.
However, VFF might be asymptomatic and often occurs in patients without osteoporosis.
Therefore, we investigated the characteristics of age-related VFF and their correlation with bone mineral density (BMD). Furthermore, we analyzed other factors affecting VFF Methods: Medical records from a single center were retrospectively reviewed for 2,216 patients over 50 years old with vertebral fractures conservatively treated from 2005 to 2016. Patients' age, gender, body mass index (BMI), BMD, fracture level, previous vertebral fractures, and anti-osteoporosis medications were obtained. Patients were divided into fragility/non-fragility groups and age sub-groups. The odds ratio for VFF in relation to BMD was evaluated. We also identified other predictive factors for VFF by age groups.
Results: The fragility group had a higher women ratio, older age, lower BMI, lower BMD, and greater incidence of previous vertebral fractures than the non-fragility group. VFFs were seen in 41.18% of normal BMD patients aged 50–59 and 67.82% of those aged 60–69. The proportion of VFFs increased with age in all WHO osteoporosis classifications. Patients with osteopenia and osteoporosis were 1.57 and 2.62 fold more likely to develop VFFs than normal BMD. In the younger group (under 70), age, women, BMD, and previous vertebral fracture were significant factors affecting VFF, and in the older group (70 and over), age, women, and BMD were factors. In the fragility group, anti-osteoporosis medication rates were 25.08% before and 45.96% after fracture.
Conclusion: Considerable VFFs occurred in the younger age groups without osteoporosis and age itself was another important predictor of VFF especially in older age groups. The discrepancy between the incidence of VFF and BMD suggests the necessity of supplemental screening factors and anti-osteoporosis treatment guidelines using only BMD should be reconsidered.

참고문헌 (Reference)

1 United Nations, "World population prospects: the 2012 revision"

2 Haczynski J, "Vertebral fractures : a hidden problem of osteoporosis" 7 (7): 1108-1117, 2001

3 Cui L, "Vertebral fracture in postmenopausal Chinese women : a population-based study" 28 (28): 2583-2590, 2017

4 Yusuf AA, "Utilization of osteoporosis medication after a fragility fracture among elderly Medicare beneficiaries" 11 (11): 31-, 2016

5 Kroth PJ, "Undertreatment of osteoporosis in women, based on detection of vertebral compression fractures on chest radiography" 2 (2): 112-118, 2004

6 Delmas PD, "Underdiagnosis of vertebral fractures is a worldwide problem : the IMPACT study" 20 (20): 557-563, 2005

7 Zeng Q, "The prevalence of osteoporosis in China, a nationwide, multicenter DXA survey" 34 (34): 1789-1797, 2019

8 Hans D, "Skeletal sites for osteoporosis diagnosis : the 2005 ISCD Official Positions" 9 (9): 15-21, 2006

9 Gehlbach SH, "Recognition of vertebral fracture in a clinical setting" 11 (11): 577-582, 2000

10 Black DM, "Prevalent vertebral deformities predict hip fractures and new vertebral deformities but not wrist fractures" 14 (14): 821-828, 1999

11 유제현, "Osteoporotic Fracture: 2015 Position Statement of the Korean Society for Bone and Mineral Research" 대한골대사학회 22 (22): 175-181, 2015

12 Valentinitsch A, "Opportunistic osteoporosis screening in multi-detector CT images via local classification of textures" 30 (30): 1275-1285, 2019

13 Marshall D, "Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures" 312 (312): 1254-1259, 1996

14 Anderson KB, "Is trabecular bone score less affected by degenerative-changes at the spine than lumbar spine BMD" 13 (13): 127-, 2018

15 Kobayashi T, "Investigation of the influencing factors on the incidence of vertebral fracture : a meta-analysis based on placebo data of randomized clinical trials" 2168479019833657-, 2019

16 Felsenberg D, "Incidence of vertebral fracture in Europe : results from the European Prospective Osteoporosis Study(EPOS)" 17 (17): 716-724, 2002

17 최성훈, "Incidence and Management Trends of Osteoporotic Vertebral Compression Fractures in South Korea: A Nationwide Population-Based Study" 대한척추외과학회 14 (14): 220-228, 2020

18 World Health Organization, "Guidelines for Preclinical Evaluation and Clinical Trials in Osteoporosis"

19 Malavolta N, "Fragility fractures : clinical and therapeutic aspects" 29 (29): 761-769, 2015

20 Schousboe JT, "Epidemiology of vertebral fractures" 19 (19): 8-22, 2016

21 Friedman SM, "Epidemiology of fragility fractures" 30 (30): 175-181, 2014

22 Siris ES, "Bone mineral density thresholds for pharmacological intervention to prevent fractures" 164 (164): 1108-1112, 2004

23 Vanasse A, "Bone mineral density measurement and osteoporosis treatment after a fragility fracture in older adults : regional variation and determinants of use in Quebec" 6 (6): 33-, 2005

24 Palermo A, "BMI and BMD : the potential interplay between obesity and bone fragility" 13 (13): E544-, 2016

25 Kanis JA, "Assessment of fracture risk and its application to screening for postmenopausal osteoporosis : synopsis of a WHO report" 4 (4): 368-381, 1994

26 World Health Organization, "Assessment of fracture risk and its application to screening for postmenopausal osteoporosis" World Health Organ 1-129, 1994

27 Kanis JA, "An update on the diagnosis and assessment of osteoporosis with densitometry. Committee of Scientific Advisors, International Osteoporosis Foundation" 11 (11): 192-202, 2000

28 Boschitsch EP, "Age-related prevalence of osteoporosis and fragility fractures : real-world data from an Austrian Menopause and Osteoporosis Clinic" 20 (20): 157-163, 2017

29 "Adult Official Positions of the ISCD"